ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Labor Analgesia in the Latent Phrase (LALP)

This study has been completed.
Study NCT00647725.   Last updated on March 31, 2008.   Information provided by Nanjing Medical University

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Labor Analgesia in the Latent Phrase
Official Title  Labor Analgesia in the Latent Phrase of the First-Stage of Spontaneous Delivery
Brief Summary

Painless labor is an essential part in woman's health care. Labor analgesia in the active phrase is in popular use currently. However, parturients are still haunted by the labor delivery pain in the latent phrase up to 7-8 hours, especially for the nulliparas. Therefore, we hypothesized that labor analgesia in the latent phrase of the first delivery stage would provide superior health care for laboring women. In addition, such analgesia technique would not prolong the time of uterine dilation and labor delivering.

Detailed Description
Study Phase
Study Type  Interventional
Study Design  Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Primary Outcome Measure  Rate of Cesarean delivery [ Time Frame: The time of the end of the labor ] [ Designated as safety issue: Yes ]
Secondary Outcome Measure  Time of latent phrase [ Time Frame: From the beginning of regular contraction of uterus to the diameter of cervix to 4cm ] [ Designated as safety issue: Yes ]
Time of labor [ Time Frame: From the beginning of regular contraction of uterus to the end of the labor ] [ Designated as safety issue: Yes ]
Overall feeling of satisfaction of analgesia [ Time Frame: From the beginning of regular contraction of uterus to the end of the labor ] [ Designated as safety issue: No ]
Side effects [ Time Frame: From the beginning of regular contraction of uterus to the end of the labor ] [ Designated as safety issue: Yes ]
VAS pain intensity [ Time Frame: From the intinition of analgesia to the cervical dilation >4cm ] [ Designated as safety issue: Yes ]
Instrumental delivery [ Time Frame: The end of the time of the labor ] [ Designated as safety issue: Yes ]
Oxytocin infusion rate [ Time Frame: During the whole period of laboring ] [ Designated as safety issue: Yes ]
Neonatal Apgar scores [ Time Frame: 1st min, 5th min, 10th min and 20th min ] [ Designated as safety issue: Yes ]
Umbilical gas measurement [ Time Frame: After delivering of the fetus ] [ Designated as safety issue: Yes ]
Maternal oral temperature [ Time Frame: From the initiation of analgesia to the end of the labor ] [ Designated as safety issue: Yes ]
Maternal corticosteroids [ Time Frame: 1h before analgesia; 0h of the analgesia; 5min,10min,30min,45min,1h,2h,3h and hourly till the end of the labor ] [ Designated as safety issue: Yes ]
Condition  Labor Pain
Intervention  Procedure: Active phrase epidural analgesia
Procedure: Latent phrase epidural analgesia
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Completed
Enrollment  15000
Start Date  January 2003
Completion Date December 2007
Eligibility Criteria 

Inclusion Criteria:

  • Nulliparas
  • Required labor analgesia
  • Chinese.

Exclusion Criteria:

  • Allergic to opioids and/or local anesthetics
  • Failed to performing epidural catheterization
  • Organic dysfunction
  • Contraindications for epidural analgesia.
Gender Female
Ages 18 Years to 45 Years
Accepts Healthy Volunteers No
Contacts ††
Location Countries  China
Administrative Information Fields
NCT ID  NCT00647725
Organization ID NMU-69714-14XS
Secondary IDs †† MCH03552
Study Sponsor  Nanjing Medical University
Collaborators ††
Investigators 
Study Director:     XiaoFeng Shen, MD     Nanjing Medical University    
Information Provided By Nanjing Medical University
Verification Date March 2008
First Received Date  March 28, 2008
Last Updated Date March 31, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers